Works matching AU Tsushima, Takahiro

Results: 94
    1

    Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials.

    Published in:
    British Journal of Surgery, 2025, v. 112, n. 6, p. 1, doi. 10.1093/bjs/znaf131
    By:
    • Okui, Jun;
    • Nagashima, Kengo;
    • Matsuda, Satoru;
    • Sato, Yasunori;
    • Kawakubo, Hirofumi;
    • Ruhstaller, Thomas;
    • Thuss-Patience, Peter;
    • Nilsson, Magnus;
    • Klevebro, Fredrik;
    • Tan, Lijie;
    • Zhang, Shaoyuan;
    • Aparicio, Thomas;
    • Piessen, Guillaume;
    • van der Zijden, Charlène;
    • Mostert, Bianca;
    • Wijnhoven, Bas P L;
    • Tsushima, Takahiro;
    • Takeuchi, Hiroya;
    • Kato, Ken;
    • Kitagawa, Yuko
    Publication type:
    Article
    2
    3
    4

    Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.

    Published in:
    Oncology, 2017, v. 93, n. 5, p. 329, doi. 10.1159/000479280
    By:
    • Komori, azusa;
    • Taniguchi, Hiroya;
    • Hamauchi, Satoshi;
    • Masuishi, Toshiki;
    • Kito, Yosuke;
    • Narita, Yukiya;
    • Tsushima, Takahiro;
    • Ishihara, Makoto;
    • Todaka, akiko;
    • Tanaka, Tsutomu;
    • Yokota, Tomoya;
    • Kadowaki, Shigenori;
    • Machida, Nozomu;
    • Ura, Takashi;
    • Fukutomi, akira;
    • ando, Masashi;
    • Onozawa, Yusuke;
    • Tajika, Masahiro;
    • Yasui, Hirofumi;
    • Muro, Kei
    Publication type:
    Article
    5
    6
    7

    Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.

    Published in:
    Oncologist, 2023, v. 28, n. 11, p. e1108, doi. 10.1093/oncolo/oyad143
    By:
    • Taniguchi, Hiroya;
    • Yamazaki, Kentaro;
    • Masuishi, Toshiki;
    • Kawakami, Takeshi;
    • Onozawa, Yusuke;
    • Honda, Kazunori;
    • Kadowaki, Shigenori;
    • Narita, Yukiya;
    • Tsushima, Takahiro;
    • Hamauchi, Satoshi;
    • Todaka, Akiko;
    • Yokota, Tomoya;
    • Ando, Masashi;
    • Mori, Keita;
    • Shirasu, Hiromichi;
    • Yasui, Hirofumi;
    • Muro, Kei
    Publication type:
    Article
    8

    aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.

    Published in:
    Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
    By:
    • Fujita, Yoshihiko;
    • Taguri, Masataka;
    • Yamazaki, Kentaro;
    • Tsurutani, Junji;
    • Sakai, Kazuko;
    • Tsushima, Takahiro;
    • Nagase, Michitaka;
    • Tamagawa, Hiroshi;
    • Ueda, Shinya;
    • Tamura, Takao;
    • Tsuji, Yasushi;
    • Murata, Kohei;
    • Taira, Koichi;
    • Denda, Tadamichi;
    • Moriwaki, Toshikazu;
    • Funai, Sadao;
    • Nakajima, Takako Eguchi;
    • Muro, Kei;
    • Tsuji, Akihito;
    • Yoshida, Motoki
    Publication type:
    Article
    9
    10

    Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials.

    Published in:
    2018
    By:
    • Yokota, Tomoya;
    • Bendell, Johanna;
    • LoRusso, Patricia;
    • Tsushima, Takahiro;
    • Desai, Ved;
    • Kenmotsu, Hirotsugu;
    • Watanabe, Junichiro;
    • Ono, Akira;
    • Murugesan, Bhavani;
    • Silva, Joseph;
    • Naito, Tateaki;
    • Greenberg, Jonathan;
    • Kumar, Prasanna;
    • Wang, Yibin;
    • Jikoh, Takahiro;
    • Shiga, Ryota;
    • Hyman, David M.;
    • Ho, Alan Loh;
    • Spriggs, David R.;
    • Schwartz, Gary K.
    Publication type:
    journal article
    11

    Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.

    Published in:
    2017
    By:
    • Sadayuki Kawai;
    • Tomoya Yokota;
    • Yusuke Onozawa;
    • Satoshi Hamauchi;
    • Akira Fukutomi;
    • Hirofumi Ogawa;
    • Tsuyoshi Onoe;
    • Tetsuro Onitsuka;
    • Takashi Yurikusa;
    • Akiko Todaka;
    • Takahiro Tsushima;
    • Yukio Yoshida;
    • Yosuke Kito;
    • Keita Mori;
    • Hirofumi Yasui;
    • Kawai, Sadayuki;
    • Yokota, Tomoya;
    • Onozawa, Yusuke;
    • Hamauchi, Satoshi;
    • Fukutomi, Akira
    Publication type:
    journal article
    12

    Phase IIb study of pembrolizumab combined with S‐1 + oxaliplatin or S‐1 + cisplatin as first‐line chemotherapy for gastric cancer.

    Published in:
    Cancer Science, 2022, v. 113, n. 8, p. 2814, doi. 10.1111/cas.15462
    By:
    • Yamaguchi, Kensei;
    • Minashi, Keiko;
    • Sakai, Daisuke;
    • Nishina, Tomohiro;
    • Omuro, Yasushi;
    • Tsuda, Masahiro;
    • Iwagami, Shiroh;
    • Kawakami, Hisato;
    • Esaki, Taito;
    • Sugimoto, Naotoshi;
    • Oshima, Takashi;
    • Kato, Ken;
    • Amagai, Kenji;
    • Hosaka, Hisashi;
    • Komine, Keigo;
    • Yasui, Hisateru;
    • Negoro, Yuji;
    • Ishido, Kenji;
    • Tsushima, Takahiro;
    • Han, Shirong
    Publication type:
    Article
    13
    14

    Phase I/ II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer ( JCOG0807).

    Published in:
    Cancer Science, 2014, v. 105, n. 9, p. 1189, doi. 10.1111/cas.12486
    By:
    • Hironaka, Shuichi;
    • Tsubosa, Yasuhiro;
    • Mizusawa, Junki;
    • Kii, Takayuki;
    • Kato, Ken;
    • Tsushima, Takahiro;
    • Chin, Keisho;
    • Tomori, Akihisa;
    • Okuno, Tatsuya;
    • Taniki, Toshikatsu;
    • Ura, Takashi;
    • Matsushita, Hisayuki;
    • Kojima, Takashi;
    • Doki, Yuichiro;
    • Kusaba, Hitoshi;
    • Fujitani, Kazumasa;
    • Taira, Koichi;
    • Seki, Shiko;
    • Nakamura, Tsutomu;
    • Kitagawa, Yuko
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.

    Published in:
    2016
    By:
    • Satake, Hironaga;
    • Tahara, Makoto;
    • Mochizuki, Satoshi;
    • Kato, Ken;
    • Hara, Hiroki;
    • Yokota, Tomoya;
    • Kiyota, Naomi;
    • Kii, Takayuki;
    • Chin, Keisho;
    • Zenda, Sadamoto;
    • Kojima, Takashi;
    • Bando, Hideaki;
    • Yamazaki, Tomoko;
    • Iwasa, Satoru;
    • Honma, Yoshitaka;
    • Hamauchi, Satoru;
    • Tsushima, Takahiro;
    • Ohtsu, Atsushi
    Publication type:
    journal article
    27
    28
    29
    30

    Phase II study of S-1 plus oxaliplatin 130 mg/m<sup>2</sup> in Japanese patients with advanced gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1084, doi. 10.1007/s10147-018-1308-1
    By:
    • Kito, Yosuke;
    • Machida, Nozomu;
    • Kawai, Sadayuki;
    • Hamauchi, Satoshi;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Yokota, Tomoya;
    • Yamazaki, Kentaro;
    • Fukutomi, Akira;
    • Onozawa, Yusuke;
    • Tsuji, Kunihiro;
    • Doyama, Hisashi;
    • Haraguchi, Yutaka;
    • Nakashima, Koji;
    • Kunieda, Kenji;
    • Taku, Keisei;
    • Mori, Keita;
    • Yasui, Hirofumi
    Publication type:
    Article
    31

    Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.

    Published in:
    International Journal of Clinical Oncology, 2018, v. 23, n. 6, p. 1189, doi. 10.1007/s10147-018-1306-3
    By:
    • Kawahira, Masahiro;
    • Yokota, Tomoya;
    • Hamauchi, Satoshi;
    • Kawai, Sadayuki;
    • Yoshida, Yukio;
    • Onozawa, Yusuke;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Machida, Nozomu;
    • Yamazaki, Kentaro;
    • Fukutomi, Akira;
    • Yasui, Hirofumi
    Publication type:
    Article
    32

    Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases.

    Published in:
    International Journal of Clinical Oncology, 2015, v. 20, n. 3, p. 455, doi. 10.1007/s10147-014-0749-4
    By:
    • Izawa, Naoki;
    • Onozawa, Yusuke;
    • Hikosaka, Tomomi;
    • Hamauchi, Satoshi;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Machida, Nozomu;
    • Haraguchi, Yutaka;
    • Ogawa, Hirofumi;
    • Nishimura, Tetsuo;
    • Nakagawa, Masahiro;
    • Fuke, Tomohito;
    • Iida, Yoshiyuki;
    • Kamijo, Tomoyuki;
    • Onitsuka, Tetsuro;
    • Boku, Narikazu;
    • Yasui, Hirofumi;
    • Yokota, Tomoya
    Publication type:
    Article
    33
    34
    35
    36

    Leptomeningeal carcinomatosis associated with gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 4, p. 361, doi. 10.1007/s10147-011-0301-8
    By:
    • Tomita, Hideharu;
    • Yasui, Hirofumi;
    • Boku, Narikazu;
    • Nakasu, Yoko;
    • Mitsuya, Koichi;
    • Onozawa, Yusuke;
    • Fukutomi, Akira;
    • Yamazaki, Kentaro;
    • Machida, Nozomu;
    • Taku, Keisei;
    • Todaka, Akiko;
    • Taniguchi, Hiroya;
    • Tsushima, Takahiro
    Publication type:
    Article
    37

    Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta.

    Published in:
    International Journal of Clinical Oncology, 2011, v. 16, n. 4, p. 359, doi. 10.1007/s10147-011-0192-8
    By:
    • Taniguchi, Hiroya;
    • Yamazaki, Kentaro;
    • Boku, Narikazu;
    • Funakoshi, Taro;
    • Hamauchi, Satoshi;
    • Tsushima, Takahiro;
    • Todaka, Akiko;
    • Sakamoto, Takeshi;
    • Tomita, Hideharu;
    • Machida, Nozomu;
    • Taku, Keisei;
    • Fukutomi, Akira;
    • Onozawa, Yusuke;
    • Tsubosa, Yasuhiro;
    • Sato, Hiroshi;
    • Nishimura, Tetsuo;
    • Yasui, Hirofumi
    Publication type:
    Article
    38

    Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.

    Published in:
    International Journal of Clinical Oncology, 2010, v. 15, n. 3, p. 287, doi. 10.1007/s10147-010-0054-9
    By:
    • Sakamoto, Takeshi;
    • Yasui, Hirofumi;
    • Boku, Narikazu;
    • Onozawa, Yusuke;
    • Hironaka, Shuichi;
    • Fukutomi, Akira;
    • Yamazaki, Kentaro;
    • Taku, Keisei;
    • Machida, Nozomu;
    • Todaka, Akiko;
    • Tomita, Hideharu;
    • Tsushima, Takahiro;
    • Taniguchi, Hiroya;
    • Hamauchi, Satoshi
    Publication type:
    Article
    39

    TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.

    Published in:
    2020
    By:
    • Bando, Hideaki;
    • Kotani, Daisuke;
    • Tsushima, Takahiro;
    • Hara, Hiroki;
    • Kadowaki, Shigenori;
    • Kato, Ken;
    • Chin, Keisho;
    • Yamaguchi, Kensei;
    • Kageyama, Shun-ichiro;
    • Hojo, Hidehiro;
    • Nakamura, Masaki;
    • Tachibana, Hidenobu;
    • Wakabayashi, Masashi;
    • Fukutani, Miki;
    • Togashi, Yosuke;
    • Fuse, Nozomu;
    • Nishikawa, Hiroyoshi;
    • Kojima, Takashi
    Publication type:
    journal article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy.

    Published in:
    Investigational New Drugs, 2024, v. 42, n. 6, p. 655, doi. 10.1007/s10637-024-01480-w
    By:
    • Hamauchi, Satoshi;
    • Yasui, Hirofumi;
    • Yokota, Tomoya;
    • Tsushima, Takahiro;
    • Fushiki, Kunihiro;
    • Naito, Tateaki;
    • Ono, Akira;
    • Kado, Nobuhiro;
    • Onozawa, Yusuke;
    • Murakami, Haruyasu;
    • Takahashi, Toshiaki;
    • Hirashima, Yasuyuki;
    • Mori, Keita;
    • Yamazaki, Kentaro
    Publication type:
    Article
    50